Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC — Stella

Home/Stage III Non-small-cell Lung Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Stage III Non-small-cell Lung Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

Aarhus University Hospital, Aarhus

Key details

Sponsor

Danish Lung Cancer Group

Collaborators

Odense University Hospital, Rigshospitalet, Denmark

Enrollment target

~151 participants

Started

November 2018

Primary completion

December 2023

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.